Metodebevisregister

Double-blind adaptive experiment

A double-blind adaptive experiment combines two powerful design features: double-blinding, which conceals treatment assignment from both participants and outcome assessors to prevent bias, and adaptive modification, which allows pre-specified changes to the trial's course — such as sample size re-estimation, allocation ratio shifts, or arm dropping — based on accumulating interim data. The result is a rigorous, bias-protected design that can respond to emerging evidence without compromising inferential validity.

Sources recorded, not reviewed

Kilderegister

Siteringer kopiert ordrett fra metodens kilderegister. Ingen påstandsnivåverifisering er underforstått fra dem.

Double-Blind Adaptive Experimental Design

Taksonomisk metoderegister · process-pipeline / experimental-design

U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL
Berry, S. M., Carlin, B. P., Lee, J. J., & Muller, P. (2010). Bayesian Adaptive Methods for Clinical Trials. CRC Press. · ISBN 9781439825488

Åpne full metode

Kuraterte påstander

Påstander lagret i bevishovedboken, hver med sin egen vurdering.

Ingen kuraterte påstander ennå

Denne visningen finner ikke opp en påstandsvurdering når hovedboken ikke har noen.

Relaterte metoder

Generert fra metodegrafen og vist som maskinforslåtte relasjoner – ingen bevispåstand er underforstått.

Taxonomic bucketAdaptive Experimentmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketMulti-arm experimentmachine-suggested · Relational suggestion, not evidence.Used in the same domainRandomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.